O7 Does viral suppressive capacity in cART-treated HIV-infected patients correlate with disease parameters, viral reservoir measures or cytotoxic T cell phenotype?

Bibliographic Details
Main Authors: P. Pannus, P. Adams, E. Willems, L. Heyndrickx, M. Van Frankenhuijsen, E. Florence, M. Kiselinova, S. Rutsaert, K. Vervisch, W. Despiegelaere, C. Devaux, L. Vandekerckhove, G. Vanham
Format: Article
Language:English
Published: Elsevier 2017-09-01
Series:Journal of Virus Eradication
Online Access:http://www.sciencedirect.com/science/article/pii/S2055664020308232
_version_ 1818598944217759744
author P. Pannus
P. Adams
E. Willems
L. Heyndrickx
M. Van Frankenhuijsen
E. Florence
M. Kiselinova
S. Rutsaert
K. Vervisch
W. Despiegelaere
C. Devaux
L. Vandekerckhove
G. Vanham
author_facet P. Pannus
P. Adams
E. Willems
L. Heyndrickx
M. Van Frankenhuijsen
E. Florence
M. Kiselinova
S. Rutsaert
K. Vervisch
W. Despiegelaere
C. Devaux
L. Vandekerckhove
G. Vanham
author_sort P. Pannus
collection DOAJ
first_indexed 2024-12-16T12:11:44Z
format Article
id doaj.art-21a27becc15c453ea5a370d771f7777e
institution Directory Open Access Journal
issn 2055-6640
language English
last_indexed 2024-12-16T12:11:44Z
publishDate 2017-09-01
publisher Elsevier
record_format Article
series Journal of Virus Eradication
spelling doaj.art-21a27becc15c453ea5a370d771f7777e2022-12-21T22:32:10ZengElsevierJournal of Virus Eradication2055-66402017-09-0133O7 Does viral suppressive capacity in cART-treated HIV-infected patients correlate with disease parameters, viral reservoir measures or cytotoxic T cell phenotype?P. Pannus0P. Adams1E. Willems2L. Heyndrickx3M. Van Frankenhuijsen4E. Florence5M. Kiselinova6S. Rutsaert7K. Vervisch8W. Despiegelaere9C. Devaux10L. Vandekerckhove11G. Vanham12Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg; AIDS Reference Clinic, Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; HIV Cure Research Center (HCRC), Ghent University, Ghent, BelgiumVirology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg; AIDS Reference Clinic, Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; HIV Cure Research Center (HCRC), Ghent University, Ghent, BelgiumVirology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg; AIDS Reference Clinic, Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; HIV Cure Research Center (HCRC), Ghent University, Ghent, BelgiumVirology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg; AIDS Reference Clinic, Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; HIV Cure Research Center (HCRC), Ghent University, Ghent, BelgiumVirology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg; AIDS Reference Clinic, Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; HIV Cure Research Center (HCRC), Ghent University, Ghent, BelgiumVirology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg; AIDS Reference Clinic, Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; HIV Cure Research Center (HCRC), Ghent University, Ghent, BelgiumVirology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg; AIDS Reference Clinic, Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; HIV Cure Research Center (HCRC), Ghent University, Ghent, BelgiumVirology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg; AIDS Reference Clinic, Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; HIV Cure Research Center (HCRC), Ghent University, Ghent, BelgiumVirology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg; AIDS Reference Clinic, Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; HIV Cure Research Center (HCRC), Ghent University, Ghent, BelgiumVirology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg; AIDS Reference Clinic, Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; HIV Cure Research Center (HCRC), Ghent University, Ghent, BelgiumVirology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg; AIDS Reference Clinic, Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; HIV Cure Research Center (HCRC), Ghent University, Ghent, BelgiumVirology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg; AIDS Reference Clinic, Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; HIV Cure Research Center (HCRC), Ghent University, Ghent, BelgiumVirology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg; AIDS Reference Clinic, Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; HIV Cure Research Center (HCRC), Ghent University, Ghent, Belgiumhttp://www.sciencedirect.com/science/article/pii/S2055664020308232
spellingShingle P. Pannus
P. Adams
E. Willems
L. Heyndrickx
M. Van Frankenhuijsen
E. Florence
M. Kiselinova
S. Rutsaert
K. Vervisch
W. Despiegelaere
C. Devaux
L. Vandekerckhove
G. Vanham
O7 Does viral suppressive capacity in cART-treated HIV-infected patients correlate with disease parameters, viral reservoir measures or cytotoxic T cell phenotype?
Journal of Virus Eradication
title O7 Does viral suppressive capacity in cART-treated HIV-infected patients correlate with disease parameters, viral reservoir measures or cytotoxic T cell phenotype?
title_full O7 Does viral suppressive capacity in cART-treated HIV-infected patients correlate with disease parameters, viral reservoir measures or cytotoxic T cell phenotype?
title_fullStr O7 Does viral suppressive capacity in cART-treated HIV-infected patients correlate with disease parameters, viral reservoir measures or cytotoxic T cell phenotype?
title_full_unstemmed O7 Does viral suppressive capacity in cART-treated HIV-infected patients correlate with disease parameters, viral reservoir measures or cytotoxic T cell phenotype?
title_short O7 Does viral suppressive capacity in cART-treated HIV-infected patients correlate with disease parameters, viral reservoir measures or cytotoxic T cell phenotype?
title_sort o7 does viral suppressive capacity in cart treated hiv infected patients correlate with disease parameters viral reservoir measures or cytotoxic t cell phenotype
url http://www.sciencedirect.com/science/article/pii/S2055664020308232
work_keys_str_mv AT ppannus o7doesviralsuppressivecapacityincarttreatedhivinfectedpatientscorrelatewithdiseaseparametersviralreservoirmeasuresorcytotoxictcellphenotype
AT padams o7doesviralsuppressivecapacityincarttreatedhivinfectedpatientscorrelatewithdiseaseparametersviralreservoirmeasuresorcytotoxictcellphenotype
AT ewillems o7doesviralsuppressivecapacityincarttreatedhivinfectedpatientscorrelatewithdiseaseparametersviralreservoirmeasuresorcytotoxictcellphenotype
AT lheyndrickx o7doesviralsuppressivecapacityincarttreatedhivinfectedpatientscorrelatewithdiseaseparametersviralreservoirmeasuresorcytotoxictcellphenotype
AT mvanfrankenhuijsen o7doesviralsuppressivecapacityincarttreatedhivinfectedpatientscorrelatewithdiseaseparametersviralreservoirmeasuresorcytotoxictcellphenotype
AT eflorence o7doesviralsuppressivecapacityincarttreatedhivinfectedpatientscorrelatewithdiseaseparametersviralreservoirmeasuresorcytotoxictcellphenotype
AT mkiselinova o7doesviralsuppressivecapacityincarttreatedhivinfectedpatientscorrelatewithdiseaseparametersviralreservoirmeasuresorcytotoxictcellphenotype
AT srutsaert o7doesviralsuppressivecapacityincarttreatedhivinfectedpatientscorrelatewithdiseaseparametersviralreservoirmeasuresorcytotoxictcellphenotype
AT kvervisch o7doesviralsuppressivecapacityincarttreatedhivinfectedpatientscorrelatewithdiseaseparametersviralreservoirmeasuresorcytotoxictcellphenotype
AT wdespiegelaere o7doesviralsuppressivecapacityincarttreatedhivinfectedpatientscorrelatewithdiseaseparametersviralreservoirmeasuresorcytotoxictcellphenotype
AT cdevaux o7doesviralsuppressivecapacityincarttreatedhivinfectedpatientscorrelatewithdiseaseparametersviralreservoirmeasuresorcytotoxictcellphenotype
AT lvandekerckhove o7doesviralsuppressivecapacityincarttreatedhivinfectedpatientscorrelatewithdiseaseparametersviralreservoirmeasuresorcytotoxictcellphenotype
AT gvanham o7doesviralsuppressivecapacityincarttreatedhivinfectedpatientscorrelatewithdiseaseparametersviralreservoirmeasuresorcytotoxictcellphenotype